Among these, the rearrangements in the anaplastic lymphoma kinase (ALK) gene account for 3-7% of NSCLC and are more frequently observed in young female, never or light-smoking patients, and with adenocarcinoma histology. The gene discussed is ALK; the disease is non-small cell lung carcinoma.